about
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...
Read More
14.95
0.85
(6.03%)
2.9M
XNAS Volume
High volume+gain today
XNAS 16 Oct, 2025 4:15 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Xencor Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..